重症监护中临床显著胸腔积液:一项前瞻性多中心队列研究
该前瞻性多中心队列研究在澳大利亚西部四家教学医院的ICU中,筛查7342例患者,纳入226例(3.1%)临床显著胸腔积液患者(胸超深度≥2 cm且临床判断对病情进展有不良影响),共300处积液。主要终点为基线至24小时PaO2:FIO2比值变化。早期引流组76例(34%)氧合显著改善(203 vs 263,+29.6%,p<0.01),而期待治疗组150例无显著改善(250 vs 268,+7.2%,p=0.44)。积液相关严重不良事件两组无差异(早期引流10.5% vs 无早期引流16.0%,p=0.32)。诊断改善见于91次初始引流(76.5%,119次中),治疗策略优化见于80次引流后(59.7%,134次中)。结论认为早期引流与氧合改善和诊断准确性提高相关,且未增加并发症。
要点
- 在ICU临床显著胸腔积液(胸超深度≥2 cm且临床判断有不良影响)患者中,24小时内早期引流使PaO2:FIO2比值从203升至263(+29.6%,p<0.01)。
- 期待治疗组PaO2:FIO2比值从250升至268(+7.2%,p=0.44),无显著改善。
- 早期引流组与无早期引流组的积液相关严重不良事件无显著差异(10.5% vs 16.0%,p=0.32)。
- 初始引流后诊断改善率为76.5%(91/119),引流后治疗策略优化率为59.7%(80/134)。
- 筛查患者中临床显著胸腔积液患病率为3.1%(226/7342)。
适用人群与场景
- 纳入标准:ICU中连续患者,胸超显示临床显著胸腔积液(深度≥2 cm且临床医生判断对患者进展有不良影响)。
- 研究场景:澳大利亚西部四家教学医院的ICU。
诊断标准与关键阈值
- 临床显著胸腔积液定义:胸超深度≥2 cm且临床医生判断对患者进展有不良影响。
处置流程与药物剂量
- 早期引流:在24小时内进行胸腔引流。
- 期待管理:未在24小时内进行引流。
研究设计与关键结果
- 研究类型:前瞻性多中心队列研究;筛查7342例,纳入226例(3.1%)患者,共300处胸腔积液。
- 早期引流组76例(34%):PaO2:FIO2比值基线203 vs 24小时263,增幅29.6%(p<0.01)。
- 期待管理组150例:PaO2:FIO2比值基线250 vs 24小时268,增幅7.2%(p=0.44)。
- 倾向评分调整后,早期引流后氧合改善保持不变。
- 积液相关严重不良事件:早期引流组10.5% vs 无早期引流组16.0%(p=0.32)。
- 诊断改善:91次初始(非重复)引流中76.5%(119次中);治疗策略优化:80次引流后59.7%(134次中)。
证据类型、等级与局限
- 证据类型:前瞻性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于ICU中临床显著胸腔积液(胸超深度≥2 cm且临床判断有不良影响)的患者,早期引流与氧合改善相关,且不增加积液相关严重不良事件。
- 早期引流可能提高诊断准确性并优化治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The prevalence and optimal management of clinically significant pleural effusion, confirmed by thoracic ultrasound, in the critically ill is unknown. This study aimed to determine: 1) the prevalence, characteristics, and outcomes of patients treated in intensive care with clinically significant effusion and 2) the comparative efficacy and safety of pleural drainage or expectant medical management.
DESIGN: A prospective multicenter cohort study.
SETTING: ICUs in four teaching hospitals in Western Australia.
PATIENTS: Consecutive patients with clinically significant pleural effusions (depth ≥ 2 cm on thoracic ultrasound with clinician-determined adverse effects on patient progress).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Primary outcome was the change in Pao2:Fio2 (mm Hg) ratio from baseline to 24 hours. Changes in diagnosis and treatment based on pleural fluid analysis and pleural effusion related serious adverse events between those who underwent either drainage within 24 hours or expectant management were compared. Of the 7,342 patients screened, 226 patients (3.1%) with 300 pleural effusions were enrolled. Early drainage of pleural effusion occurred in 76 patients (34%) and significantly improved oxygenation (Pao2:Fio2 ratio 203 at baseline vs 263 at 24 hr, +29.6% increment; p < 0.01). This was not observed in the other 150 patients who had expectant management (Pao2:Fio2 ratio 250 at baseline vs 268 at 24 hr, +7.2% increment; p = 0.44). The improvement in oxygenation after early drainage remained unchanged after adjustment for a propensity score on the decision to initiate early drainage. Pleural effusion related serious adverse events were not different between the two groups (early drainage 10.5% vs no early drainage 16.0%; p = 0.32). Improvements in diagnosis were noted in 91 initial (nonrepetitive) drainages (76.5% out of 119); treatment strategy was optimized after 80 drainage episodes (59.7% out of 134).
CONCLUSIONS: Early drainage of clinically significant pleural effusion was associated with improved oxygenation and diagnostic accuracy without increased complications.
参考来源
- Fysh ETH, Smallbone P, Mattock N, et al. Clinically Significant Pleural Effusion in Intensive Care: A Prospective Multicenter Cohort Study. Crit Care Explor. 2020. PMID: 32166290. doi:10.1097/CCE.0000000000000070
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。